Connect with us

Business

JAKK Tuesdays' Liquor Licence permanently revoked – Kingston News – Kingstonist

Published

 on


J.A.K.K. Tuesdays, located on Progress Avenue in Kingston’s west end, on Friday, Nov. 12, 2021. Photo by Cris Vilela.

After months of back and forth between business owner Kelly Hale and various regulatory provincial and municipal authorities, the Liquor Licence for his bar, J.A.K.K. Tuesdays, has been permanently revoked.

The Alcohol and Gaming Commission of Ontario (AGCO) ordered an Order of Interim Suspension of the liquor licence of J.A.K.K. Tuesdays, “for reasons of public interest and safety” on Thursday, Sept 30, 2021, and also announced its intentions to seek permanent revocation of the licence the same day. This came two weeks after the business announced its intentions to not comply with COVID-19 protocols under the provincial Reopening of Ontario Act (ROA), particularly the mandatory enforcement of proof of vaccination to enter establishments like the bar.

While awaiting the decision of the Licence Appeal Tribunal regarding that revocation, the business continued to violate legislation and Public Health protocols, resulting in its loss of business licence through the municipality of the City of Kingston and being served with a Section 22 Order by Kingston, Frontenac, Lennox and Addington (KFL&A) Public Health on Wednesday, Nov. 3, 2021. Additionally, J.A.K.K. Tuesdays – which continued to remain open to the public despite all of these things – saw multiple visits from KFL&A Public Health through the first two weeks of November, all documenting the business’ non-compliance, which culminated in the sports bar being served with a Superior Court Order on Wednesday, Nov. 10, 2021. Again, Hale refused to close his business, and remained in non-compliance as documented by KFL&A Public Health the following day.

And, as the week came to an end, so, too, did the business’ ability to legally serve alcohol, as the Licence Appeal Tribunal issued its decision on Friday, Nov. 12, 2021.

“The independent Licence Appeal Tribunal (LAT) has issued its decision. The order directs the AGCO to carry out the Registrar’s proposal to revoke J.A.K.K. Tuesdays’ liquor licence,” the AGCO said in a statement.

“The AGCO’s revocation of the liquor licence means the operator cannot legally sell or serve alcohol in this establishment.”

Despite this, the business still remained open as of 6 p.m. on Friday, Nov. 12, 2021. While the neon ‘Open’ sign was not illuminated in the business’ window, people inside could clearly be seen sitting at the bar of the establishment. A woman outside the bar, identifying herself as “the bouncer”, said they were having a private party and encouraged arriving patrons to “BYOB.”

Patrons can clearly be seen inside J.A.K.K. Tuesdays on Friday, Nov. 12, 2021. Photo by Cris Vilela.

The provincial regulatory board continued, outlining its reasoning for the suspension of J.A.K.K. Tuesdays liquor licence and the proposal to revoke that licence entirely.

“Requiring proof of vaccination in select settings allows businesses to keep operating while protecting the safety of Ontarians. The operators of liquor licensed establishments have an important role to play in keeping the sector open and the community safe,” the AGCO stated.

“We appreciate and recognize all the establishments that are taking this responsibility seriously and will continue addressing situations where that responsibility is being disregarded.”

Kingstonist has requested a full copy of the LAT decision, and will provide updates when that information becomes available.

Adblock test (Why?)



Source link

Continue Reading

Business

Google real estate executive says 5% more workers coming in to office each week

Published

 on

Alphabet Inc’s Google has seen an increasing number of employees coming in to its offices each week, particularly younger workers, the company’s real estate chief said during an interview at the Reuters Next conference on Friday.

On Thursday, Google indefinitely pushed back the mandated return date for employees due to concerns about the Omicron variant. The company had previously said its 150,000 global employees could be required to come in to the office as soon as Jan. 10.

Nevertheless, David Radcliffe, Google’s vice president for real estate and workplace services, said many Googlers are returning of their own volition. About 40% of its U.S. employees on average came in to the office daily in recent weeks, up from 20-25% three months ago, he said. Globally, 5% more employees are returning to offices week after week, he added.

“People are actually showing voluntarily that they want to be back in the office,” Radcliffe said. “We’re moving in the right direction.”

Younger employees and those who joined Google more recently have been coming in at higher rates, seeking opportunities to learn from colleagues, Radcliffe added.

Google expects workers in the office at least three days a week once it mandates a new return date.

Based on feedback from those already back, it is redesigning floor plans to increase private, quiet spaces for distraction-free individual work and adding conferencing and other collaboration areas in open spaces both indoors and outdoors.

Real estate and human resources experts have considered Google a trailblazer for the past 20 years in sustainable office design and variety of workplace perks, including free meals, massages and gyms.

To extend those sustainability and wellness benefits to remote work, Google has encouraged employees to buy carbon offsets and non-toxic furniture for their home offices. It also has provided free cooking classes and discounts to fitness studios near workers’ homes.

“It was amazing how many employees had really never cooked themselves,” Radcliffe said.

 

(Reporting by Paresh Dave in Oakland, Calif., and Julia Love in San Francisco; Editing by Sonya Hepinstall and Matthew Lewis)

Continue Reading

Business

S&P/TSX composite down nearly 200 points, U.S. stock markets also lower – Business News – Castanet.net

Published

 on


Canada’s main stock index was down nearly 200 points in late-morning trading, led lower by losses in the technology, base metal and industrial sectors, while U.S. stock markets also fell.

The S&P/TSX composite index was down 176.86 points at 20,585.17.

In New York, the Dow Jones industrial average was down 160.83 points at 34,478.96. The S&P 500 index was down 48.14 points at 4,528.96, while the Nasdaq composite was down 341.27 points at 15,040.05.

The Canadian dollar traded for 78.05 cents US compared with 78.03 cents US on Thursday.

The January crude oil contract was up US$1.54 at US$68.04 per barrel and the January natural gas contract was up eight cents at US$4.14 per mmBTU.

The February gold contract was up US$14.90 at US$1,777.60 an ounce and the March copper contract was down two cents at US$4.28 a pound.

Adblock test (Why?)



Source link

Continue Reading

Business

Canada secures orders of Merck, Pfizer COVID-19 antiviral pills – Globalnews.ca

Published

 on


The federal government has signed purchase agreements with two pharmaceutical companies for their oral COVID-19 treatments.

Filomena Tassi, Canada’s minister of public services and procurement, told reporters on Friday the government has signed agreements with Pfizer and Merck to buy up to 1.5 million courses of their antiviral treatment, PF-07321332 and Molnupiravir.

Both treatments are under Health Canada review, Tassi added.

“We also know that access to effective, easy-to-use treatments is critical to reducing the severity of COVID infections and will help save lives,” she said.

“As soon as these drugs are authorized for use, the government will work on getting them to provinces and territories as quickly as possible so that health-care providers can help Canadians who need them most.”

Read more:

Canadians 18+ should be offered COVID-19 booster 6 months after 2nd shot, NACI says

As part of its initial order, the government has reached an agreement with Pfizer for one million courses of its treatment, pending Health Canada approval.

The government’s deal with Merck is for up to 500,000 courses of its treatment, with an option to add 500,000 more pending approval, Tassi added.


Click to play video: 'Pfizer, Merck press ahead with pills to treat COVID-19'



2:12
Pfizer, Merck press ahead with pills to treat COVID-19


Pfizer, Merck press ahead with pills to treat COVID-19 – Nov 5, 2021

On Wednesday, Pfizer started a rolling submission with Health Canada for its pill, which it said is designed to block a key enzyme needed for the COVID-19 virus to multiply.

Pfizer also said its treatment can cut the chance of hospitalization or death for adults at risk of severe disease by 89 per cent.

Read more:

COVID-19 antiviral pill approved in U.K. still being reviewed by Health Canada

Meanwhile, Merck’s pill is still under review by Health Canada as the company continues its rolling submission.

Last week, Merck shared data suggesting its drug was significantly less effective than previously thought, reducing hospitalizations and deaths in high-risk individuals by around 30 per cent.

The treatment has received approval in the United Kingdom.

— with files from The Canadian Press and Reuters

© 2021 Global News, a division of Corus Entertainment Inc.

Adblock test (Why?)



Source link

Continue Reading

Trending